Trial · NCT06931054
Combination of Acupuncture, Auricular Acupressure and Nicotine Replacement Therapy for Smoking Cessation
NCT06931054, Not applicable, Recruiting, The University of Hong Kong
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Combination of Acupuncture, Auricular Acupressure and Nicotine Replacement Therapy for Smoking Cessation. Trials, record NCT06931054. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06931054
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Combination of Acupuncture, Auricular Acupressure and Nicotine Replacement Therapy for Smoking Cessation
- NCT number
- NCT06931054
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 270 participants, estimated
- Lead sponsor
- The University of Hong Kong
- Conditions
- Smoking
- Interventions
- Acupuncture, Nicotine Replacement therapy, Smoking cessation counseling, Auricular acupressure, Sham acupressure, Sham acupuncture
- First posted
- 2025-04-16
- Last updated
- 2025-05-11
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Biochemical validated tobacco abstinence at 26-week follow-up | 26-week follow-up | Biochemically verified quitting is defined as a carbon monoxide (CO) level in exhaled breath measured by a CO monitor of less than or equal to 3 ppm, and a salivary cotinine level of less than or equal to 30 ng/ml, as tested by a cotinine test strip. |
| Secondary | Biochemical validated tobacco abstinence at 8-week follow-up | 8-week follow-up | Biochemically verified quitting is defined as a carbon monoxide (CO) level in exhaled breath measured by a CO monitor of less than or equal to 3 ppm |
| Secondary | Self-reported 7-day point prevalence abstinence at 8-week follow-up | 8-week follow-up | Self-reported 7-day point prevalence abstinence |
| Secondary | Self-reported 7-day point prevalence abstinence at 26-week follow-up | 26-week follow-up | Self-reported 7-day point prevalence abstinence |
| Secondary | Incidence rate of side effects/adverse events | 8-week follow-up | Incidence rate of side effects/adverse events (e.g., needle fainting, bleeding, etc.). |
| Secondary | Number of cigarettes smoked per day at the 8-week follow-up | 8 weeks | Number of cigarettes smoked per day (in smokers) |
| Secondary | Number of cigarettes smoked per day at the 26-week follow-up | 26-week follow-up | Number of cigarettes smoked per day (in smokers) |
| Secondary | Withdrawal symptoms | 8 weeks | Minnesota Nicotine Withdrawal Scale (MNWS), measured through ecological momentary assessment, scale range from 7 to 35, higher scores mean more frequent withdrawal symptoms |
| Secondary | Questionnaire of Smoking Urges-Brief (QSU-B) | 8 weeks | The 10-item Questionnaire of Smoking Urges-Brief (QSU-B) is used to measure the desire and anticipation of smoking |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06931054
GET https://conductscience.org/api/trials/v1/NCT06931054/registered